KAWAJIRI, H., TAKASHIMA, T., ONODA, N., KASHIWAGI, S., NODA, S., ISHIKAWA, T., . . . HIRAKAWA, K. (2012). Efficacy and feasibility of neoadjuvant chemotherapy with FEC 100 followed by weekly paclitaxel for operable breast cancer. D.A. Spandidos.
Styl cytowania ChicagoKAWAJIRI, HIDEMI, TSUTOMU TAKASHIMA, NAOYOSHI ONODA, SHINICHIRO KASHIWAGI, SATORU NODA, TETSUROU ISHIKAWA, KENICHI WAKASA, i KOSEI HIRAKAWA. Efficacy and Feasibility of Neoadjuvant Chemotherapy With FEC 100 Followed By Weekly Paclitaxel for Operable Breast Cancer. D.A. Spandidos, 2012.
Styl cytowania MLAKAWAJIRI, HIDEMI, et al. Efficacy and Feasibility of Neoadjuvant Chemotherapy With FEC 100 Followed By Weekly Paclitaxel for Operable Breast Cancer. D.A. Spandidos, 2012.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..